GL1X · GenesisL1 explorer

MolNFT v1 · #119959 · protein

Crystal structure of sle patient-derived anti-DNA antibody

5GKS · IGG2, Fab (heavy chain): “Crystal structure of sle patient-derived anti-DNA antibody”. X-ray diffraction, 1 ligand (PO4), 5 pockets (best druggability 0.74). MolNFT v1 #119959 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
5GKS
Type
protein
Length
826 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
IGG2, Fab (heavy chain); Lambda, Fab (light chain)
Ligands
PO4
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIGG2, Fab (heavy chain)protein2069% helix, 53% strand—
BLambda, Fab (light chain)protein2116% helix, 51% strand—
CIGG2, Fab (heavy chain)protein2008% helix, 55% strand—
DLambda, Fab (light chain)protein2097% helix, 51% strand—

Ligands and binding sites

  • PO4 · Phosphate ion · ion · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111480.740.7798empty
26720.670.7652empty
31620.470.7630empty
4740.330.7519empty
5700.290.7315empty

Interfaces

3 interfaces between chains.

  • A–B · 1793 Ų buried · 8 hydrogen bonds · protein-protein
  • C–D · 1746 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 848 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 5GKS · Crystal structure of SLE patient-derived anti-DNA antibody · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.